🇺🇸 FDA
Pipeline program

mannitol and microcrystalline cellulose, Tolebrutinib

EFC16035

Phase 3 small_molecule active

Quick answer

mannitol and microcrystalline cellulose, Tolebrutinib for Primary Progressive Multiple Sclerosis is a Phase 3 program (small_molecule) at Genzyme Europe B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Genzyme Europe B.V.
Indication
Primary Progressive Multiple Sclerosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials